3
Participants
Start Date
July 28, 2023
Primary Completion Date
November 14, 2024
Study Completion Date
February 24, 2025
SerpinPC
Administered as SC injection.
Taichung Veterans General Hospital, Taichung
Royal Prince Alfred Hospital, Camperdown
The Alfred Hospital, Melbourne
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico, Milan
East Carolina University, Greenville
Hospital Universitario La Paz, Madrid
University of South Florida, Tampa
Istanbul University Oncology Institute, Istanbul
Ege University Medical Faculty Hospital, Izmir
Chung Shan Medical University, Taichung
China Medical University Hospital, Taichung
CHRU de Lille Centre de biologie et pathologie, Lille
University Hospital Frankfurt M, Frankfurt
Hospices Civils de Lyon (HCL) - Hopital Femme-Mere-Enfant (HFME), Lyon
Hopital Necker - Enfants Malades, Paris
Hopital Bicetre, Le Kremlin-Bicêtre
K J Somaiya Super Speciality Hospital & Research Centre, Mumbai
University of Colorado School of Medicine, Aurora
Centre of Haematology named after prof. R. O. Yeolian/ Hemophilia center, Yerevan
Nottingham University Hospitals NHS Trust, Nottingham
Lead Sponsor
Collaborators (1)
Centessa Pharmaceuticals plc
INDUSTRY
ApcinteX Ltd
INDUSTRY